- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04797169
Noom Health for Weight Management
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A total of 600 subjects will be enrolled in a randomized-controlled trial comparing the Noom app (Noom Health) to a digital control (Noom Digital Health) with 6 months of intervention and 6 months active maintenance in both groups. Measures will include demographics, psychosocial measures, height/weight, waist circumference, weight loss history/practices, health care practices/utilization, and quality of life.
Participants will complete informed consent and interviews via a HIPAA-compliant videoconference (Zoom) and other questionnaires via a REDCap interface. All participants will complete screening/baseline procedures to determine eligibility and initial information. Subsequently, they will be randomized to one of the groups for a 6-month intervention and 6- month maintenance period (12 months total).
In Noom Health, participants will be encouraged to use the app multiple times per day to log eating episodes, physical activity and weight. Coaches will also interact with participants directly through the app. In Noom Digital Health, participants will use a simplified version to log eating episodes and weight. Both conditions will receive the same weight loss advice content.
During the intervention, participants will complete monthly satisfaction surveys. Additionally, follow-up measures will be conducted at 7 time points (Screening/Baseline, 1 month, 4 months, 6 months, 12 months, 18 months, 24 months, and 30 months).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10028
- Department of Psychiatry, Eating and Weight Disorders Program
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants must be interested in the Noom app
- BMI > 27 kg/m2
- Ages of 18 and 60 at entry to the study
- Speak English
Exclusion Criteria:
- Contraindication to smartphone use (e.g., seizures from prior smartphone use, do not own a smartphone)
- Acute suicide risk
- Pregnant or planning to become pregnant during the study
- Current Noom use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Noom Health
|
In Noom Health, participants will be encouraged to use the Noom app multiple times a day to log eating episodes, physical activity and weight.
They will also have the ability to interact with coaches to receive advice and feedback specific to weight loss.
|
|
Active Comparator: Noom Digital Health
|
In Noom Digital Health, participants will use a simplified version to log eating episodes and weight.
Both conditions will receive the same weight loss advice content.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Weight From Baseline
Time Frame: Baseline, 6 months and 30 Months
|
Weight at 6 months and 30 months as compared to baseline.
Weight will be documented using staff-led Zoom calls and taken with the participant's home scale.
|
Baseline, 6 months and 30 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent of Successful Technological Fixes
Time Frame: Baseline and 12 Months
|
App compatibility will be examined by calculating the percent of successful technological fixes at 12 months as compared to baseline.
The type of technological problems encountered by participants while using the app and any fixes needed will be categorized.
|
Baseline and 12 Months
|
|
Change in CDC NCHS National Health Interview Survey
Time Frame: Baseline and 30 Months
|
Changes in health status from baseline to 30-months as measured by questions from the CDC NCHS National Health Interview Survey.
Using an adapted version of the CDC NCHS National Health Interview Survey, the survey includes 4 questions about healthcare utilization.
Items identify type of healthcare sought and frequency.
The frequency of provider visits will be calculated to determine healthcare utilization.
A frequency score of zero indicates no healthcare utilized.
There is no upper limit for the frequency.
|
Baseline and 30 Months
|
|
Change in Caloric Intake Using the Automated Self-Administered Recall System (ASA24) From Baseline to 30 Months
Time Frame: Baseline and 30 Months
|
Caloric intake at 30 months as compared to baseline.
Caloric intake will be measured using the ASA24 dietary recall system.
|
Baseline and 30 Months
|
|
Change in Dietary Behavior Using the Eating Disorder Examination Questionnaire (EDE-Q) From Baseline to 30 Months
Time Frame: Baseline and 30 Months
|
EDE-Q global score at 30 months as compared to baseline.
Dietary restraint, eating, shape, and weight concerns are measured with the EDE-Q.
These subscales are summed and then divided by the total number of subscales (4) to create a global score.
Scores range from 0 to 52 with higher scores indicating higher severity.
|
Baseline and 30 Months
|
|
Change in Physical Activity Using the International Physical Activity Questionnaire (IPAQ) From Baseline to 30 Months
Time Frame: Baseline and 30 Months
|
Physical activity at 30 months as compared to baseline.
The IPAQ includes 27 items and determines a MET value for time spent in an average week completing different levels of activity including vigorous or moderate physical activity, walking, and sitting.
One MET is the energy spent sitting at rest.
|
Baseline and 30 Months
|
|
Change in Depression Using the Depression Anxiety Stress Scales (DASS) From Baseline to 30 Months
Time Frame: Baseline and 30 Months
|
Depression subscale score at 30 months as compared to baseline.
DASS is a 42-item self-report scale of negative emotional states with subscales of depression, anxiety, and stress.
Each subscale is scored 0-42, with total score from 0-126.
Higher scores indicate more severe psychological distress.
|
Baseline and 30 Months
|
|
Change in Anxiety Using the Depression Anxiety Stress Scales (DASS) From Baseline to 30 Months
Time Frame: Baseline and 30 Months
|
Anxiety subscale score at 30 months as compared to baseline.
DASS is a 42-item self-report scale of negative emotional states with subscales of depression, anxiety, and stress.
Each subscale is scored 0-42, with total score from 0-126.
Higher scores indicate more severe psychological distress.
|
Baseline and 30 Months
|
|
Change in Stress Using the Depression Anxiety Stress Scales (DASS) From Baseline to 30 Months
Time Frame: Baseline and 30 Months
|
Stress subscale score at 30 months as compared to baseline.
DASS a 42-item self-report scale of negative emotional states with subscales of depression, anxiety, and stress.
Each subscale is scored 0-42, with total score from 0-126.
Higher scores indicate more severe psychological distress.
|
Baseline and 30 Months
|
|
Change in Sleep Impairment Using the PROMIS Sleep Related Impairment Survey From Baseline to 30 Months
Time Frame: Baseline and 30 Months
|
Sleep impairment at 30 months as compared to baseline.
The PROMIS Sleep Related Impairment v.1.0 is a 16-item self-report measure of perceived functioning during waking hours in relation to tiredness and trouble sleeping.
A raw score is calculated by summing all individual items and is translated into a T-score with standard error (SE).
A T-score of 50 indicates normal impairment compared to the general population, scores above 50 indicate more impairment.
|
Baseline and 30 Months
|
|
Change in Physical Composite Score (PCS) Using the Short-Form-36 (SF-36) From Baseline to 30 Months
Time Frame: Baseline and 30 Months
|
PCS at 30 months as compared to baseline.
The SF-36 is a 36-item self-report health-related quality of life assessment of physical functioning, limitations, energy, emotional well-being, social functioning, pain and general health.
Scores range from 17.2- 66.7 with lower scores indicating worse quality of life related to physical health.
|
Baseline and 30 Months
|
|
Change in Mental Composite Score (MCS) Using the Short-Form-36 (SF-36) From Baseline to 30 Months
Time Frame: Baseline and 30 Months
|
MCS at 30 months as compared to baseline.
The SF-36 is a 36-item self-report health-related quality of life assessment of physical functioning, limitations, energy, emotional well-being, social functioning, pain and general health.
Scores range from 12.7-64.2
with lower scores indicating worse quality of life related to mental health.
|
Baseline and 30 Months
|
|
Change in Self-Efficacy for Healthy Eating Using the Diet Self-Efficacy Scale (DIET-SE) From Baseline to 30 Months
Time Frame: Baseline and 30 Months
|
Self-efficacy at 30 months as compared to baseline.
The DIET-SE is an 11-item self-report assessment of healthy eating with scales specific to temptations, social/internal factors, and negative emotional related to resistance.
The score ranges from 0 - 40 with higher scores indicating more self-efficacy.
|
Baseline and 30 Months
|
|
Adherence to Intervention Measured Using a Percentage of the Total Number of Available App Features Used at 6 Months
Time Frame: 6 Months
|
The percent of available features on the app, expected verses completed at 6 months
|
6 Months
|
|
Number of Participants With 12-Month Completion Status
Time Frame: 12 Months
|
Attrition at 12 months as compared to number randomized at baseline documented using completion status
|
12 Months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Thomas Hildebrandt, PsyD, Icahn School of Medicine at Mount Sinai
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GCO 20-2224
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Noom Health
-
Noom Inc.Icahn School of Medicine at Mount SinaiCompleted
-
Noom Inc.Icahn School of Medicine at Mount SinaiCompleted
-
Noom Inc.CompletedQuality of Life | Obesity | Overweight and Obesity | Health BehaviorUnited States
-
Yale UniversityBoehringer Ingelheim; MedullanCompletedCongestive Heart FailureUnited States
-
Noom Inc.CompletedObesity | Weight LossUnited States
-
Milton S. Hershey Medical CenterWithdrawnLiver Diseases | NASH - Nonalcoholic Steatohepatitis | NASH
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH); Noom Inc.; Kaiser Foundation Hospitals...CompletedBulimia Nervosa | Binge Eating DisorderUnited States
-
Icahn School of Medicine at Mount SinaiKaiser Permanente; Noom Inc.Completed
-
Noom Inc.Stony Brook UniversityCompleted
-
Milton S. Hershey Medical CenterNoom Inc.CompletedNon-alcoholic SteatohepatitisUnited States